| Authors: |
Freeman TP; Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath BA2 7AY, UK; Clinical Psychopharmacology Unit, University College London, London, UK; Translational Psychiatry Research Group, Research Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: t.p.freeman@bath.ac.uk., Hindocha C; Clinical Psychopharmacology Unit, University College London, London, UK; Translational Psychiatry Research Group, Research Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK; National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK., Baio G; Department of Statistical Science, University College London, London, UK., Curran HV; Clinical Psychopharmacology Unit, University College London, London, UK; National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK. |